"Since taking your topical skin creams ProEstro and BipProgest I am stating to feel like my old self again from before I went into my life change. Thank you Geromatrix for your high quality, all natural and safe products"
Sherry S. - Los Angeles, CA "I have just started using Contropres AF and within a week noticed that it worked better than Holistrol which I have been using for two years. You found a customer for life and I plan on trying your other products over the next few months."
Roy S - Detroit, MI View All Testimonials » |
 |
|
A Natural Supplement for Healthy BonesFor healthy, stronger bones today and for your future. Live active, live strong with maximum bone and connective tissue health. | | | | At age 40, a woman starts to be concerned with osteoporosis and menopause. Factors such as age, dietary intake, exercise and hereditary factor, affect the bone density of human body. These are very genuine concerns due to the facts that osteoporosis starts in the mid-thirties, plus 8% of women are now entering menopause by the age of 38. Osteoporosis is a high risk factor due to the demineralization of bones and often results in pathological fractures. The unfortunate rise in surgically induced menopause from ovary removal during hysterectomy is also lowering the onset age of menopause. |
| | Our Price $32.95 | | | | Retail Price $36.95 | | | Other Reasons for Concern: - During menopause estrogen levels drop, causing concern of osteoporosis, cardiovascular disease, hot flashes and mood swings.
- As many as one in two women and one in eight men will suffer a fracture due to osteoporosis.
- Every 5% decrease in bone density increases the risk of fracture by 40%.
- Half of all bone loss occurs pre-menopausal.
- Peek bone mass is achieved around age 30, after which bone loss may start to occur at a rate of 1% per year.
- Rise in number of surgically induced menopause.
Osteo Support provides a synergistic combination of highly bio-available forms of calcium, magnesium and other minerals, together with vitamin D3 and K1, demonstrated by basic scientific research and clinical studies to support bone health. Osteoporosis, cardiovascular disease, hot flashes and mood swings can all result from the onset of menopause and the corresponding drop of estrogen levels. Osteoporosis is also a concern for men as they grow older. Every 5% decrease in bone density increases the risk of fracture by 40%. Osteo Support's unique combination of nutrients can help combat bone loss and increase bone density by providing calcium in its most readily absorbed form.
After the age of 30, new bone formation starts to lag behind bone resorption. Severe loss of bone mineral density is called osteoporosis, whilst the less severe form is termed osteopenia. Regular exercise and a healthy diet are key elements in maintaining bone mineral density as is good balance of oestrogen and progesterone. Oestrogen is known to key into the bone resorption cells (osteoclasts) and progesterone is known to key into the bone building cells (osteoblasts). Stress can also be a deteriorating factor in bone health, so whilst it is important to ensure optimal intake of the vitamins and minerals necessary for bone health, it is also vital to be aware of hormonal influences.
Selected Active Ingredients:
- Ipriflavone - Ipriflavone with calcium decreases bone loss and maintains or increases bone density. A number of double-blind, placebo-controlled studies have demonstrated that 200 mg. a day of ipriflavone, in combination with 1200mg. calcium, decreased bone loss significantly and increased bone density, compared to the placebo group. 11 In a two-year study in Siena, Italy, 56 postmenopausal women with low bone density were randomly assigned to receive either 200 mg. of ipriflavone three times a day or a placebo. All subjects also received 1,200 mg per day of calcium. The women taking only the calcium showed a 5% decline in bone density. However, the women taking ipriflavone and calcium showed no bone density loss. 12
- Calcium Citrate - Test comparing the calcium forms of citrate and carbonate show that there is a hyper-absorption of calcium in individuals taking calcium citrate. Additional tests, which also were conducted on individuals with low levels of stomach acid, found that those using calcium carbonate produced an antacid effect in the stomach that interfered with digestion and thus calcium absorption. 1,3,4,5
- Boron - a trace element, which is found in relatively high levels of apples, pears, grapes, nuts and leafy vegetables. A recent study has linked increased Boron levels to increased levels of estrogen. Estrogen replacement therapy has long been used as a means of preventing Calcium loss in postmenopausal women. The study confirms that 3.0 mg of Boron per day markedly reduces urinary excretion of Calcium, Magnesium, and Phosphorous. 6,7
- Magnesium - Collective studies indicate that magnesium in combination with boron, phosphorus, silicon, and of course calcium is needed to maintain healthy bones. A 400 mg dosage of elemental magnesium is a sufficient amount not only to aid in calcium absorption and utilization, but also in the reduction of muscle spasms and cramps. 8,9,10
- Copper - essential for growth and development of the skeletal system.
- Copper helps low bone turnover by suppressing osteoclasts (breaks down bone)
- Helps construct the protein matrix that builds bone. 13
- Vitamin K1 (phylloquinone)- derived exclusively from food. About 70% of the daily intake of Vitamin K is excreted making it important to get a daily supply to maintain adequate levels. Vitamin K, found in both hard and soft bone acts as a cofactor in synthesizing osteocalcin, an important compound involved in bone calcification.
- Has been shown to increase bone density in women with vertebral compression fracture due to osteoporosis.
- Increases bone formation in postmenopausal women.
- Deficiency in men associated with osteopenia.
- Postmenopausal women with low levels of Vitamin K have lower bone density than those with normal levels. 13
Usage:
As a dietary supplement, adults take four (4) tablets daily with meals or as directed by your healthcare practitioner
NOTE: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
REFERENCES: 1. Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta-analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
2. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age or older. N Engl J Med. 1997; 337:670-676.
3. Heaney RP, Dowell MS, Barger-Lux MJ. Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporosis Int. 1999; 9:19-23.
4. Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73.
5. Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
6. Chapin RE, Ku WW, Kenny MA, Mc Coy H, Gladen B, Wine RN, Wilson R, Elwell MR. The effects of dietary boron on bone strength in rats. Fundam Appl Toxical. 1997; 35:205 215.
7. Nielsen FH, Gallagher SK, Johnson LK, Nielsen EJ. Boron enhances and mimics some effects of estrogen therapy in postmenopausal women. J Trace Elem Exp Med. 1992; 5: 237-246.
8. Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
9. Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
10. Toba Y, Kajita Y, Masuyama R, et al. Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. J Nutr. 2000; 130:216-220.
11. Turner, Lisa. “Supplement Spotlight: Ipriflavone.” Vitamin Retailer. July 2000; 48-53.
12. Gennari C, et al. Effect of Ipriflavone-a Synthetic Derivative of Natural Isoflavone- on Bone Mass Loss in Early Years After Menopause. Menopause 1998; 5: 9-15.
13. Germano, Carl. “The Osteoporosis Solution: New Therapies for Prevention and Treatment”. 1999. New York: Kensington Books. |
|
|
|
